Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Operating Leases (2020 - 2025)

Historic Operating Leases for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $9.4 million.

  • Mirum Pharmaceuticals' Operating Leases fell 590.83% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 590.83%. This contributed to the annual value of $8.0 million for FY2024, which is 119205.83% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Operating Leases of $9.4 million as of Q3 2025, which was down 590.83% from $10.0 million recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Operating Leases registered a high of $10.0 million during Q3 2024, and its lowest value of $617000.0 during Q4 2023.
  • Moreover, its 5-year median value for Operating Leases was $1.9 million (2021), whereas its average is $3.9 million.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Operating Leases plummeted by 5091.49% in 2023, and later surged by 119205.83% in 2024.
  • Over the past 5 years, Mirum Pharmaceuticals' Operating Leases (Quarter) stood at $1.9 million in 2021, then plummeted by 33.95% to $1.3 million in 2022, then tumbled by 50.91% to $617000.0 in 2023, then surged by 1192.06% to $8.0 million in 2024, then rose by 17.86% to $9.4 million in 2025.
  • Its Operating Leases was $9.4 million in Q3 2025, compared to $10.0 million in Q2 2025 and $8.6 million in Q1 2025.